9969 — InnoCare Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapNeutral

Annual balance sheet for InnoCare Pharma, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6,287	9,054	8,285	7,217	7,236
Net Total Accounts Receivable
Net Total Receivables	66.2	145	319	363	507
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6,417	9,300	8,765	7,820	8,062
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	546	696	834	818	781
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	7,415	10,329	9,920	9,407	10,824
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	317	2,068	2,082	1,049	1,384
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,810	2,732	2,772	2,682	3,097
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	5,605	7,597	7,148	6,725	7,727
Total Liabilities & Shareholders' Equity	7,415	10,329	9,920	9,407	10,824
Total Common Shares Outstanding